Syndax Pharmaceuticals Inc (SNDX)
15.60
-0.35
(-2.19%)
USD |
NASDAQ |
Nov 21, 16:00
15.59
-0.01
(-0.06%)
After-Hours: 20:00
Syndax Pharmaceuticals Max Drawdown (5Y): 61.18% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 61.18% |
| September 30, 2024 | 68.30% |
| August 31, 2024 | 68.30% |
| July 31, 2024 | 68.30% |
| June 30, 2024 | 68.30% |
| May 31, 2024 | 68.30% |
| April 30, 2024 | 68.30% |
| March 31, 2024 | 71.40% |
| February 29, 2024 | 73.15% |
| January 31, 2024 | 73.15% |
| December 31, 2023 | 75.13% |
| November 30, 2023 | 78.98% |
| October 31, 2023 | 78.98% |
| September 30, 2023 | 78.98% |
| August 31, 2023 | 78.98% |
| July 31, 2023 | 78.98% |
| June 30, 2023 | 78.98% |
| May 31, 2023 | 78.98% |
| April 30, 2023 | 78.98% |
| March 31, 2023 | 78.98% |
| February 28, 2023 | 78.98% |
| January 31, 2023 | 78.98% |
| December 31, 2022 | 78.98% |
| November 30, 2022 | 78.98% |
| October 31, 2022 | 78.98% |
| Date | Value |
|---|---|
| September 30, 2022 | 78.98% |
| August 31, 2022 | 78.98% |
| July 31, 2022 | 78.98% |
| June 30, 2022 | 78.98% |
| May 31, 2022 | 78.98% |
| April 30, 2022 | 78.98% |
| March 31, 2022 | 78.98% |
| February 28, 2022 | 78.98% |
| January 31, 2022 | 78.98% |
| December 31, 2021 | 78.98% |
| November 30, 2021 | 78.98% |
| October 31, 2021 | 78.98% |
| September 30, 2021 | 78.98% |
| August 31, 2021 | 78.98% |
| July 31, 2021 | 78.98% |
| June 30, 2021 | 78.98% |
| May 31, 2021 | 78.98% |
| April 30, 2021 | 78.98% |
| March 31, 2021 | 78.98% |
| February 28, 2021 | 78.98% |
| January 31, 2021 | 78.98% |
| December 31, 2020 | 78.98% |
| November 30, 2020 | 78.98% |
| October 31, 2020 | 78.98% |
| September 30, 2020 | 78.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
61.18%
Minimum
Oct 2024
78.98%
Maximum
Nov 2019
77.23%
Average
78.98%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Vertex Pharmaceuticals Inc | 41.60% |
| Moderna Inc | -- |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 8.692 |
| Beta (5Y) | 0.9194 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 64.09% |
| Historical Sharpe Ratio (5Y) | 0.3208 |
| Historical Sortino (5Y) | 0.7229 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.06% |